Erratum to robotic lobectomy has the greatest benefit in patients with marginal pulmonary function
Erratum

Erratum to robotic lobectomy has the greatest benefit in patients with marginal pulmonary function

Monica Casiraghi1, Lorenzo Spaggiari1,2

1Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, Milan, Italy; 2Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy

Correspondence to: Dr. Monica Casiraghi. Division of Thoracic Surgery, IEO, European Institute of Oncology, Via G. Ripamonti, 435 20141 Milan, Italy. Email: monica.casiraghi@ieo.it.

doi: 10.21037/jtd.2019.09.13


Erratum to: J Thorac Dis 2019;11:S322-4.


Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function

In the article that appeared on Page S322-S324, Vol 11, Suppl 3 (March 2019) Issue of the Journal of Thoracic Disease (JTD) (1), an affiliation was mistakenly translated, and it should have read as follow: Division of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

It has been corrected in this corrigendum. The authors would like to apologize for any inconvenience caused.


References

  1. Casiraghi M, Spaggiari L. Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function. J Thorac Dis 2019;11:S322-4. [Crossref] [PubMed]
Cite this article as: Casiraghi M, Spaggiari L. Erratum to robotic lobectomy has the greatest benefit in patients with marginal pulmonary function. J Thorac Dis 2019;11(9):E151. doi: 10.21037/jtd.2019.09.13